MOTS-c

Research

Mitochondrial ORF of 12S rRNA-c

Aliases
Mitochondrial peptide MOTS-c
Administration
Subcutaneous injection

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Limited data on human side effects

This compound has not been extensively studied in humans, so its full side-effect profile remains uncertain.